KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Operating Leases (2019 - 2025)

Biolife Solutions (BLFS) has disclosed Operating Leases for 7 consecutive years, with $12.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Leases rose 2.02% to $12.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.9 million, a 2.02% increase, with the full-year FY2025 number at $12.9 million, up 2.02% from a year prior.
  • Operating Leases was $12.9 million for Q4 2025 at Biolife Solutions, up from $11.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $18.0 million in Q1 2023 to a low of $8.7 million in Q4 2023.
  • A 5-year average of $14.3 million and a median of $15.1 million in 2022 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: skyrocketed 67957.69% in 2021, then tumbled 41.89% in 2023.
  • Biolife Solutions' Operating Leases stood at $16.5 million in 2021, then fell by 9.13% to $15.0 million in 2022, then crashed by 41.89% to $8.7 million in 2023, then skyrocketed by 45.43% to $12.6 million in 2024, then rose by 2.02% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Operating Leases are $12.9 million (Q4 2025), $11.0 million (Q3 2025), and $11.6 million (Q2 2025).